Uni-Bio Science Group Limited (00690) announced its Monthly Return for January 2026, indicating no change in authorized share capital, which remains at 500,000,000,000 ordinary shares with a par value of HK$0.01 each. The total authorized share capital stands at HK$5,000,000,000. The issuer’s total number of issued shares also remained at 5,971,228,147, with no treasury shares recorded.

The announcement showed that a set of 22,000,000 share options, previously part of the 2006 Share Option Scheme, lapsed during this period. The company confirmed compliance with the applicable public float requirement, maintaining at least 25% of the total number of issued ordinary shares in public hands. No other share option movements, warrant issuances, convertible issuances, or share repurchases were detailed under the reported categories.